More than 18 million people in the U.S. suffer from Obstructive Sleep Apnea (OSA). About 85% of sufferers are undiagnosed and therefore untreated generating significant medical expense for patients and the healthcare system. While there are sleep labs that are in place, these labs aren't necessarily convenient for the patient.

Royal DSM (Heerlen, the Netherlands) said that it has entered into a definitive agreement with Kensey Nash (Exton, Pennsylvania) under which DSM would acquire all the outstanding shares of common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.50 in cash per share for total enterprise value of about $360 million.

Cohera Medical (Pittsburgh), a developer of absorbable surgical adhesives and sealants, reported the treatment of the first patient in a prospective, multicenter, randomized clinical trial for its lead product, TissuGlu surgical adhesive in the U.S.

Years ago at another publication, one of my former colleagues made one of the greatest rookie mistakes a person could make during their career. He triumphantly displayed how much money he was being paid to several reporters in the newsroom. The pandemonium was classic. Many marched up to management and demanded salary adjustments, using this poor naïve writer's pay as a "negotiating" ground. I wonder if something similar to this scenario will play out when the Physican Payment Sunshine Act will go into effect. I realize that med-tech said that it doesn't mind the transparency, but are companies considering the...